Articles  News Headlines  Journal Headlines   Home   Archives   Site Map May 23, 2013   About AIDScience Contact Us ——

Search Journal Headlines Archive   Enter a word or phrase you want to search for: Found: 405 records. Note: For details on a journal headline, click on the title Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection Vaccine. (Posted: December 11, 2003) The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector Vaccine. (Posted: December 11, 2003) Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines Virology. (Posted: December 11, 2003) HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses Proc. Natl. Acad. Sci. USA. (Posted: December 8, 2003) Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development Proc. Natl. Acad. Sci. USA. (Posted: December 8, 2003) Review: Immunodeficiency virus exploitation of dendritic cells in the early steps of infection Journal of Leukocyte Biology. (Posted: December 2, 2003) Review: The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys Journal of Leukocyte Biology. (Posted: December 2, 2003) Review: Macrophage HIV-1 infection and the gastrointestinal tract reservoir Journal of Leukocyte Biology. (Posted: December 2, 2003) HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China AIDS. (Posted: November 20, 2003) Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1 Journal of Immunology. (Posted: November 12, 2003) Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals Vaccine. (Posted: November 12, 2003) The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases Vaccine. (Posted: November 12, 2003) The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients Vaccine. (Posted: November 12, 2003) Modified Vaccinia Virus Ankara (MVA) priming and Fowlpox Virus booster elicit stronger CD8+ T cell response in mice against an HIV-1 epitope than DNA-Poxvirus prime-booster approach Biotechnology and Applied Biochemistry. (Posted: November 12, 2003) Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity Journal of Immunology. (Posted: November 11, 2003) Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses Journal of Immunology. (Posted: November 11, 2003) M cell DNA vaccination for CTL immunity to HIV Journal of Immunology. (Posted: November 11, 2003) Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge Journal of Immunology. (Posted: November 11, 2003) Microparticles and nanoparticles as delivery systems for DNA vaccines Crit. Rev. Ther. Drug. Carrier Syst.. (Posted: November 10, 2003) Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine Immunology Letters. (Posted: November 10, 2003) Safety evaluation of GX-12, a new HIV therapeutic vaccine: Investigation of integration into the host genome and expression in the reproductive organs Intervirology. (Posted: November 10, 2003) Peptide immunogens based on the envelope region of HIV-1 are recognized by HIV/AIDS patient polyclonal antibodies and induce strong humoral immune responses in mice and rabbits Molecular Immunology. (Posted: November 10, 2003) Gradual adaptation of HIV to human host populations: good or bad news? Nature Medicine. (Posted: November 10, 2003) IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaques AIDS Research and Human Retroviruses. (Posted: November 7, 2003) Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: Associations with viral replication and progression Journal of Medical Virology. (Posted: November 7, 2003) Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O Virus Research. (Posted: November 7, 2003) Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets Blood. (Posted: November 7, 2003) Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: Poorer control of a pathogenic viral challenge AIDS Research and Human Retroviruses. (Posted: November 7, 2003) Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways Journal of Biological Chemistry. (Posted: November 6, 2003) Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS Journal of Virology. (Posted: November 3, 2003) Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects AIDS. (Posted: October 29, 2003) Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic HIV-1 isolate Journal of Virology. (Posted: October 27, 2003) Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge Journal of Virology. (Posted: October 27, 2003) Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes Journal of Virology. (Posted: October 27, 2003) Microarray profiling of antibody responses against simian-human immunodeficiency virus: Postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen Journal of Virology. (Posted: October 23, 2003) Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: Characterization of CD8+-T-cell epitopes recognized Journal of Virology. (Posted: October 23, 2003) Oral vaccination of mice with adenoviral vectors Is not impaired by preexisting immunity to the vaccine carrier Journal of Virology. (Posted: October 22, 2003) Enhancement of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope gene fused to the gene coding for soluble CTLA4 Journal of Virology. (Posted: October 22, 2003) Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome Journal of Virology. (Posted: October 22, 2003) AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine Journal of Virology. (Posted: October 22, 2003) Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans Journal of Infectious Diseases. (Posted: October 14, 2003) Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans AIDS. (Posted: October 9, 2003) AIDS vaccines that allow HIV-1 to infect and escape immunologic control: A mathematic analysis of mass vaccination Journal of Acquired Immune Deficiency Syndromes. (Posted: October 9, 2003) Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies Journal of Immunology. (Posted: October 6, 2003) Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells Journal of Immunology. (Posted: October 6, 2003) Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL Journal of Immunology. (Posted: October 6, 2003) Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection Journal of Immunology. (Posted: October 6, 2003) How the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past Vaccine. (Posted: October 2, 2003) Ii-Key/MHC class II epitope hybrid peptide vaccines for HIV Vaccine. (Posted: October 2, 2003) Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity. Vaccine. (Posted: October 2, 2003) Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa Vaccine. (Posted: October 2, 2003) Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins Vaccine. (Posted: October 2, 2003) Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach Vaccine. (Posted: October 2, 2003) HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the MHC class II compartment, and elicits enhanced immune responses Journal of Biological Chemistry. (Posted: September 30, 2003) Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA) Peptides. (Posted: September 30, 2003) Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4(+) and CD8(+) T-Cell responses Journal of Acquired Immune Deficiency Syndromes. (Posted: September 29, 2003) Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses Journal of Acquired Immune Deficiency Syndromes. (Posted: September 29, 2003) SIVagm: Genetic and biological features associated with replication Frontiers in Bioscience. (Posted: September 29, 2003) CD4(+) T cell signaling in the natural SIV host — Implications for disease pathogenesis Frontiers in Bioscience. (Posted: September 29, 2003) Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials Biometrics. (Posted: September 29, 2003) Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys Frontiers in Bioscience. (Posted: September 29, 2003) Enhanced cell-mediated IFN-gamma-secreting activity against the HIV-1(IIIB)V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering Biochem. Biophys. Res. Commun.. (Posted: September 29, 2003) Health and human rights: Thorny issues in the ethics of AIDS vaccine trials The Lancet. (Posted: September 23, 2003) Health and human rights: HIV-1 care in resource-poor settings: a view from Haiti The Lancet. (Posted: September 23, 2003) Health and human rights: Provision of treatment in HIV-1 vaccine trials in developing countries The Lancet. (Posted: September 23, 2003) Health and human rights: Not if but how? Caring for HIV-1 vaccine trial participants in South Africa The Lancet. (Posted: September 23, 2003) Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 Journal of Virology. (Posted: September 16, 2003) Yeast-derived human immunodeficiency virus type 1 p55gag virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8+ T cells by cross-presentation of DCs Journal of Virology. (Posted: September 15, 2003) Cellular immunity elicited by HIV-1/SIV DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies Journal of Virology. (Posted: September 15, 2003) Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells Journal of Virology. (Posted: September 15, 2003) ELDKWA-epitope-specific monoclonal antibodies inhibit HIV envmediated syncytium formation Immunobiology. (Posted: September 12, 2003) Synthetic vaccines: The role of adjuvants in immune targeting Current Medicinal Chemistry. (Posted: September 2, 2003) Unique risks to volunteers in HIV vaccine trials Journal of Investigative Medicine. (Posted: September 2, 2003) T cell targeted immune enhancement yields effective T cell adjuvants International Immunopharmacology. (Posted: September 2, 2003) Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B Journal of Virology. (Posted: August 29, 2003) Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system Journal of Virology. (Posted: August 29, 2003) Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities Journal of Virology. (Posted: August 29, 2003) Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys Journal of Virology. (Posted: August 29, 2003) Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen Journal of Immunology. (Posted: August 20, 2003) Most highly exposed seronegative men lack HIV-1-specific, IFN-{gamma}-secreting T cells Journal of Immunology. (Posted: August 20, 2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda AIDS. (Posted: August 20, 2003) Prime-boost vaccination with HIV-1 gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses Journal of Immunology. (Posted: August 20, 2003) Convergent evolution of SIV env after independent inoculation of rhesus macaques with infectious proviral DNA Vaccine. (Posted: August 19, 2003) AIDSVAX results: an important open question Vaccine. (Posted: August 19, 2003) Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA Vaccine. (Posted: August 19, 2003) Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr–SIVenv/rev and Ad5hr–SIVgag recombinants Vaccine. (Posted: August 19, 2003) Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha Journal of Experimental Medicine. (Posted: August 18, 2003) A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand AIDS Research and Human Retroviruses. (Posted: August 18, 2003) Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion Journal of Molecular Biology. (Posted: August 18, 2003) Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection Microbes and Infection. (Posted: August 18, 2003) Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes Journal of General Virology. (Posted: August 14, 2003) Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model Journal of Virology. (Posted: August 14, 2003) Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-SIV env/rev, gag, and/or nef vaccines and boosted with SIV gp120 Journal of Virology. (Posted: August 8, 2003) Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines Journal of Virology. (Posted: August 8, 2003) Induction of protective immune responses against R5 HIV-1 infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells Journal of Virology. (Posted: August 8, 2003) Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells AIDS. (Posted: August 4, 2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env Blood. (Posted: July 29, 2003) In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice Archives of Pharmacal Research. (Posted: July 29, 2003) Role of complement in the control of HIV dynamics and pathogenesis Vaccine. (Posted: July 29, 2003) Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1 FEMS Immunology and Medical Microbiology. (Posted: July 29, 2003) Specific nature of cellular immune responses elicited by chimpanzees against HIV-1 Human Immunology. (Posted: July 29, 2003) Innate and adaptive mucosal immunity in protection against HIV infection Vaccine. (Posted: July 29, 2003) Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 gag in mice AIDS Research and Human Retroviruses. (Posted: July 29, 2003) Identification and characterization of HLA-A*3303-restricted, HIV type 1 pol- and gag-derived cytotoxic T cell epitopes AIDS Research and Human Retroviruses. (Posted: July 29, 2003) First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection Virology. (Posted: July 25, 2003) Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251 Virology. (Posted: July 25, 2003) DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles Journal of General Virology. (Posted: July 23, 2003) Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities Journal of Acquired Immune Deficiency Syndromes. (Posted: July 23, 2003) Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients Journal of Virology. (Posted: July 16, 2003) A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV Journal of Gene Medicine. (Posted: July 16, 2003) Improved protection of rhesus macaques against intrarectal SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen Journal of Virology. (Posted: July 16, 2003) Anti-human immunodeficiency virus-gag CD8(+) memory T cells generated in vitro from Listeria-immunized mice Immunology. (Posted: July 16, 2003) Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant European Journal of Immunology. (Posted: July 16, 2003) Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines AIDS Reviews. (Posted: July 15, 2003) Antibody protection: passive immunization of neonates against oral AIDS virus challenge Vaccine. (Posted: July 11, 2003) Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals Vaccine. (Posted: July 11, 2003) Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin Vaccine. (Posted: July 11, 2003) Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1 FEMS Immunology and Medical Microbiology. (Posted: July 11, 2003) Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials Vaccine. (Posted: July 11, 2003) Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults Journal of Infectious Diseases. (Posted: July 10, 2003) Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice Proc. Natl. Acad. Sci. USA. (Posted: July 10, 2003) HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals Journal of Immunology. (Posted: July 10, 2003) What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials Journal of Infectious Diseases. (Posted: July 10, 2003) Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression AIDS Research and Human Retroviruses. (Posted: July 2, 2003) Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O AIDS Research and Human Retroviruses. (Posted: July 2, 2003) Kunjin virus replicon vectors for human immunodeficiency virus vaccine development Journal of Virology. (Posted: June 30, 2003) Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1 Journal of Virology. (Posted: June 30, 2003) Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science. (Posted: June 27, 2003) The need for a global HIV vaccine enterprise Science. (Posted: June 27, 2003) Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection Journal of Immunology. (Posted: June 27, 2003) Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nature Medicine. (Posted: June 24, 2003) Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences Journal of Virology. (Posted: June 17, 2003) Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys Journal of Virology. (Posted: June 16, 2003) Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene Journal of Virology. (Posted: June 16, 2003) The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand AIDS. (Posted: June 12, 2003) Viewpoint — Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries Lancet. (Posted: May 27, 2003) A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12 Journal of Virology. (Posted: May 27, 2003) Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against HIV Env systemically and in the genitorectal draining lymph nodes Journal of Virology. (Posted: May 27, 2003) HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children Journal of Immunology. (Posted: May 27, 2003) Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins Virology. (Posted: May 21, 2003) Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines Journal of Virology. (Posted: May 20, 2003) Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a HIV-1 gag gene Journal of Virology. (Posted: May 20, 2003) Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women AIDS. (Posted: May 19, 2003) Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization AIDS. (Posted: May 19, 2003) Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis Journal of Clinical Investigation. (Posted: May 16, 2003) Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants Vaccine. (Posted: May 13, 2003) Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study) Vaccine. (Posted: May 13, 2003) Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination Vaccine. (Posted: May 13, 2003) Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming Vaccine. (Posted: May 13, 2003) The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag Journal of Immunology. (Posted: May 12, 2003) Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers Journal of Acquired Immune Deficiency Syndromes. (Posted: May 12, 2003) Infection of macaques with an R5-tropic SHIV bearing a chimeric envelope carrying subtype E V3 loop among subtype B framework Archives of Virology. (Posted: May 12, 2003) HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand Journal of Acquired Immune Deficiency Syndromes. (Posted: May 12, 2003) Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones Journal of Clinical Virology. (Posted: May 12, 2003) HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals Clinical and Experimental Immunology. (Posted: May 9, 2003) Induction of broad and potent anti-HIV immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles Journal of Virology. (Posted: May 2, 2003) Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120 Journal of Virology. (Posted: May 2, 2003) Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants To enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins Journal of Virology. (Posted: May 1, 2003) Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design Journal of Virology. (Posted: May 1, 2003) Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses Journal of Immunological Methods. (Posted: April 26, 2003) Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection Biomedicine & Pharmacotherapy. (Posted: April 26, 2003) Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1 Journal of Virology. (Posted: April 17, 2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection Proc. Natl. Acad. Sci. USA. (Posted: April 14, 2003) Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6 Virology. (Posted: April 14, 2003) Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner Journal of Infectious Diseases. (Posted: April 7, 2003) HIV-1 vaccine development: Constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb Biochemistry. (Posted: April 4, 2003) Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination Journal of Virology. (Posted: April 2, 2003) Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual Journal of Immunology. (Posted: March 25, 2003) Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting FEMS Immunology and Medical Microbiology. (Posted: March 20, 2003) Human immunodeficiency virus seropositivity among uninfected HIV vaccine recipients Journal of Infectious Diseases. (Posted: March 17, 2003) Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein Journal of Virology. (Posted: March 17, 2003) Immunogenicity of a recombinant HIV canarypox vaccine in HIV-seronegative Ugandan volunteers: Results of the HIV Network for Prevention Trials 007 vaccine study Journal of Infectious Diseases. (Posted: March 17, 2003) Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12 Journal of Virology. (Posted: March 17, 2003) nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes Journal of Virology. (Posted: March 17, 2003) Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity Proc. Natl. Acad. Sci. USA. (Posted: March 17, 2003) Primary African HIV clade A and D isolates: Effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B AIDS Research and Human Retroviruses. (Posted: March 10, 2003) A new perspective on V3 phenotype prediction AIDS Research and Human Retroviruses. (Posted: March 10, 2003) Characterization and selection of HIV-1 subtype C isolates for use in vaccine development AIDS Research and Human Retroviruses. (Posted: March 10, 2003) Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus Journal of Virology. (Posted: March 6, 2003) Candidate HIV/AIDS vaccines: Lessons learned from the world's first phase III efficacy trials AIDS. (Posted: March 4, 2003) Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand Journal of Immunology. (Posted: February 27, 2003) Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias Journal of Immunology. (Posted: February 27, 2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature. (Posted: February 27, 2003) Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men AIDS. (Posted: February 25, 2003) Estimating cumulative probabilities from incomplete longitudinal binary responses with application to HIV vaccine trials Statistics in Medicine. (Posted: February 21, 2003) Quantitative assessment of antigen-specific CD8+T cells in the mouse: application to vaccine research Immunology Letters. (Posted: February 21, 2003) Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor Journal of Virology. (Posted: February 19, 2003) SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization Journal of Virology. (Posted: February 19, 2003) Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system Journal of Virology. (Posted: February 19, 2003) Tat-neutralizing antibodies in vaccinated macaques Journal of Virology. (Posted: February 19, 2003) Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials Journal of Acquired Immune Deficiency Syndromes. (Posted: February 19, 2003) Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies Journal of Biological Chemistry. (Posted: February 12, 2003) Comparison between Env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults Journal of Acquired Immune Deficiency Syndromes. (Posted: February 12, 2003) Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or Interferon-g Virology. (Posted: February 12, 2003) Construction and immunogenicity in a prime–boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine Journal of General Virology. (Posted: February 10, 2003) Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat Vaccine. (Posted: February 10, 2003) HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania AIDS Research and Human Retroviruses. (Posted: February 10, 2003) Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice Journal of Medical Virology. (Posted: February 5, 2003) A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus macaques Vaccine. (Posted: February 4, 2003) Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella Vaccine. (Posted: February 4, 2003) Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity Vaccine. (Posted: February 4, 2003) Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic Blood. (Posted: February 4, 2003) Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost Journal of General Virology. (Posted: February 4, 2003) Reviews on human immunodeficiency virus central nervous system disease Journal of Neurovirology. (Posted: February 4, 2003) A systematic comparison of methods to measure HIV-1 specific CD8 T cells Journal of Immunological Methods. (Posted: February 4, 2003) Antigen burden is a major determinant of human immunodeficiency virus specific CD8+ T cell maturation state: Potential implications for therapeutic immunization Journal of Infectious Diseases. (Posted: February 4, 2003) Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies Virology. (Posted: February 4, 2003) Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes Nature Biotechnology. (Posted: February 4, 2003) Virus-like particle and DNA-based candidate AIDS vaccines Vaccine. (Posted: February 4, 2003) Priming of human immunodeficiency virus type 1 (HIV-1) specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins Journal of Infectious Diseases. (Posted: February 3, 2003) Moving to human immunodeficiency virus type 1 vaccine efficacy trials: Defining T cell responses as potential correlates of immunity Journal of Infectious Diseases. (Posted: February 3, 2003) Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance responses to immunization: Results of A5046s Journal of Infectious Diseases. (Posted: February 3, 2003) Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region Journal of Virology. (Posted: January 31, 2003) Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system Journal of Virology. (Posted: January 31, 2003) Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation AIDS. (Posted: January 30, 2003) CD4-dependent and CD4-independent HIV-2: consequences for neutralization AIDS. (Posted: January 30, 2003) Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques AIDS. (Posted: January 30, 2003) A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag Journal of Immunology. (Posted: January 23, 2003) Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus Journal of Virology. (Posted: January 22, 2003) Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites Journal of Virology. (Posted: January 22, 2003) Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d Journal of Virology. (Posted: January 22, 2003) Scaling HIV vaccine attitudes among gay men in Sydney, Australia AIDS Research and Human Retroviruses. (Posted: January 16, 2003) Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy AIDS Research and Human Retroviruses. (Posted: January 16, 2003) Effect of promoters on cellular immune response induced by recombinant fowlpox virus expressing multi-epitope polypeptides from HIV-1 Biotechnology and Applied Biochemistry. (Posted: January 13, 2003) Is HIV superinfection worrisome? Lancet. (Posted: January 13, 2003) Synthetic AIDS vaccine by targeting HIV receptor Vaccine. (Posted: January 13, 2003) Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya Vaccine. (Posted: January 13, 2003) HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating Virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses Journal of Immunology. (Posted: January 12, 2003) Travel and the spread of HIV-1 genetic variants Lancet Infectious Diseases. (Posted: January 9, 2003) Course and outcome of pregnancy in 54 persistently HIV-1-seronegative sex workers and their infants Journal of Reproductive Medicine. (Posted: January 8, 2003) Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells Journal of Virology. (Posted: January 6, 2003) Prevention of disease induced by a partially heterologous AIDS virus in Rhesus monkeys by using an adjuvanted multicomponent protein vaccine Journal of Virology. (Posted: January 6, 2003) Control of viremia and prevention of SHIV-induced disease in Rhesus macaques immunized with recombinant vaccinia viruses plus inactivated SIV and HIV-1 particles Journal of Virology. (Posted: January 6, 2003) Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection Journal of Virology. (Posted: January 6, 2003) Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIVSF162P3 maps to envelope gp120 Journal of Virology. (Posted: January 6, 2003) Immunization of newborn Rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251 Journal of Virology. (Posted: January 3, 2003) Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8+ cytotoxic T lymphocytes Journal of Virology. (Posted: January 3, 2003) Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus Journal of Virology. (Posted: January 3, 2003) Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 Journal of Virology. (Posted: January 2, 2003) Concordant modulation of neutralization resistance and high infectivity of the primary HIV-1 MN strain and definition of a potential gp41 binding site in gp120 Journal of Virology. (Posted: January 2, 2003) Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies Journal of Virology. (Posted: January 2, 2003) Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial Journal of Acquired Immune Deficiency Syndromes. (Posted: December 26, 2002) Therapeutic dendritic-cell vaccine for simian AIDS Nature Medicine. (Posted: December 24, 2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature. (Posted: December 17, 2002) Recombinant multi-epitope vaccine induced predefined epitope-specific antibodies against HIV-1 Immunology Letters. (Posted: December 17, 2002) Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells Journal of Immunology. (Posted: December 8, 2002) T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev AIDS. (Posted: December 4, 2002) Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions AIDS. (Posted: December 4, 2002) HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades AIDS. (Posted: December 3, 2002) Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector Vaccine. (Posted: November 25, 2002) Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre- and postchallenge CD4(+) and CD8(+) T cell responses Journal of Immunology. (Posted: November 18, 2002) Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion Journal of Virology. (Posted: November 12, 2002) Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development Virology. (Posted: November 12, 2002) The functional CD8 T cell response to HIV becomes type-specific in progressive disease Journal of Clinical Investigation. (Posted: November 6, 2002) HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades AIDS. (Posted: October 31, 2002) Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice Vaccine. (Posted: October 31, 2002) Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? Journal of Virology. (Posted: October 31, 2002) Both mMucosal and systemic routes of immunization with the live, attenuated NYVAC/SIVgpe recombinant vaccine result in Gag-specific CD8+ T-cell responses in mucosal tissues of macaques Journal of Virology. (Posted: October 31, 2002) Evaluation in rhesus macaques of Tat and Rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08 DNA and Cell Biology. (Posted: October 25, 2002) A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L Proc. Natl. Acad. Sci. USA. (Posted: October 25, 2002) Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus Virology. (Posted: October 25, 2002) Lymphoid activation: a confounding factor in AIDS vaccine development? Journal of General Virology. (Posted: October 25, 2002) In vivo priming of HIV-specific CTLs determines selective cross-reactive immune responses against poorly immunogenic HIV-natural variants Journal of Immunology. (Posted: October 25, 2002) HIV-1 Tat-based vaccines: From basic science to clinical trials DNA and Cell Biology. (Posted: October 25, 2002) Targeting Tat and IFN alpha as a therapeutic AIDS vaccine DNA and Cell Biology. (Posted: October 25, 2002) Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes DNA and Cell Biology. (Posted: October 25, 2002) Prime-boost immunization with DNA and MVA vectors expressing herpes simplex virus-2 glycoprotein d elicits greater specific antibody and cytokine responses than DNA vaccine alone. The Journal of Infectious Diseases. (Posted: October 21, 2002) Preparation of clinical-grade recombinant canarypox human immunodeficiency virus vaccine loaded human dendritic cells The Journal of Infectious Diseases. (Posted: October 21, 2002) Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection Journal of Virology. (Posted: October 18, 2002) A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine Vaccine. (Posted: October 11, 2002) Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques Journal of Medical Primatology. (Posted: October 11, 2002) Characterization of CD4+T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus Journal of Medical Primatology. (Posted: October 11, 2002) Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates Journal of Medical Primatology. (Posted: October 11, 2002) Cross-clade T lymphocyte-mediated immunity to HIV type 1: Implications for vaccine design and immunodetection assays AIDS Research and Human Retroviruses. (Posted: October 11, 2002) AIDS vaccines, immunology, and what we have learned The AIDS Reader. (Posted: October 10, 2002) Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments Journal of Human Virology. (Posted: October 7, 2002) Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41 AIDS. (Posted: October 1, 2002) Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4(+) T cells Clinical and Experimental Immunology. (Posted: September 23, 2002) Comparison of the efficacy of early versus late viral proteins in vaccination against SIV Vaccine. (Posted: September 14, 2002) Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element DNA and Cell Biology. (Posted: September 14, 2002) Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines Journal of Virology. (Posted: September 14, 2002) Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine Vaccine. (Posted: September 14, 2002) Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with HIV gag DNA vaccines Journal of Virology. (Posted: September 4, 2002) Next generation DNA vaccines for HIV-1 Journal of Liposome Research. (Posted: September 3, 2002) Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand Journal of Acquired Immune Deficiency Syndromes. (Posted: September 3, 2002) DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses Blood. (Posted: September 3, 2002) Design and tests of an HIV vaccine British Medical Bulletin. (Posted: August 29, 2002) HIV-1 therapeutic vaccines Journal of Infection. (Posted: August 19, 2002) Semi-allogeneic vaccines for patients with cancer and AIDS Journal of Immunotherapy. (Posted: August 19, 2002) Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects Journal of Acquired Immune Deficiency Syndromes. (Posted: August 19, 2002) The HIV-1 vaccine race Cell. (Posted: August 19, 2002) A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice Proc. Natl. Acad. Sci. USA. (Posted: August 15, 2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy Lancet Infectious Diseases. (Posted: August 2, 2002) Strategies for an HIV vaccine Journal of Clinical Investigation. (Posted: July 29, 2002) The development of HIV-1 subtype C vaccines for southern Africa IUBMB Life. (Posted: July 29, 2002) Alphavirus replicon particles as candidate HIV vaccines IUBMB Life. (Posted: July 29, 2002) Immuno-informatics: Mining genomes for vaccine components Immunology and Cell Biology. (Posted: July 24, 2002) T-lymphocyte epitope identification and their use in vaccine development for HIV-1 Frontiers in Bioscience. (Posted: July 24, 2002) Human Immunodeficiency Virus-Specific CD8+ T Cells in Human Breast Milk Journal of Virology. (Posted: July 19, 2002) AIDS Vaccination Studies Using an Ex Vivo FIV Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts Journal of Virology. (Posted: July 19, 2002) Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines Journal of Virology. (Posted: July 19, 2002) Enhanced Presentation of MHC Class I-Restricted HIV-1 Gag-Specific Epitopes after DNA Immunization with Vectors Coding for Vesicular Stomatitis Virus Glycoprotein- Pseudotyped HIV-1 Gag Particles Journal of Virology. (Posted: July 19, 2002) Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C Vaccine. (Posted: July 19, 2002) Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico Vaccine. (Posted: July 19, 2002) Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection Archives of Virology. (Posted: July 5, 2002) HIV/AIDS treatment and HIV vaccines for Africa Lancet. (Posted: June 28, 2002) Diversity considerations in HIV-1 vaccine selection Science. (Posted: June 28, 2002) HIV-1 diversity and vaccine development Science. (Posted: June 28, 2002) Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines AIDS Research and Human Retroviruses. (Posted: June 28, 2002) Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques Vaccine. (Posted: June 25, 2002) Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge Vaccine. (Posted: June 25, 2002) Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication Journal of Virology. (Posted: June 21, 2002) Critical role for Env as well as Gag-Pol in control of a SHIV 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine Journal of Virology. (Posted: June 21, 2002) Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials Vaccine. (Posted: June 21, 2002) Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes Proc. Natl. Acad. Sci. USA. (Posted: June 12, 2002) Special issue of the journal Vaccine: several titles Vaccine. (Posted: June 1, 2002) Human immunodeficiency virus type 1 subtype C molecular phylogeny: Consensus sequence for an AIDS vaccine design? Journal of Virology. (Posted: May 29, 2002) Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya Journal of Acquired Immune Deficiency Syndromes. (Posted: May 25, 2002) Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination Clinical and Experimental Immunology. (Posted: May 24, 2002) Fusion-competent vaccines: Broad neutralization of primary isolates of HIV (Retraction of vol 283, pg 357, 1999) Science. (Posted: May 20, 2002) Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes Proc. Natl. Acad. Sci. USA. (Posted: May 14, 2002) Issues for improving multiplasmid DNA vaccines for HIV-1 Vaccine. (Posted: May 14, 2002) Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric env protein boost in the SHIV rhesus macaque model Virology. (Posted: May 7, 2002) Prospects for an AIDS vaccine (letter) Science. (Posted: May 7, 2002) Prospects for vaccine protection against HIV-1 infection and AIDS Annual Review of Immunology. (Posted: May 7, 2002) HIV preferentially infects HIV-specific CD4+ T cells Nature. (Posted: May 2, 2002) A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines Journal of Controlled Release. (Posted: April 25, 2002) Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies Journal of Biological Chemistry. (Posted: April 18, 2002) HIV vaccine development in the nonhuman primate model of AIDS Journal of Biomedical Science. (Posted: April 18, 2002) HIV-1 polymorphism: A challenge for vaccine development - A review Memorias do Instituto Oswaldo Cruz. (Posted: April 11, 2002) Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques Journal of General Virology. (Posted: April 11, 2002) Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma Journal of Virology. (Posted: April 11, 2002) Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022A Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002) DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus Journal of Medical Primatology. (Posted: April 3, 2002) Clinical trials of HIV vaccines Annual Review of Medicine. (Posted: April 3, 2002) Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine Journal of Virology. (Posted: April 3, 2002) Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate Journal of Immunology. (Posted: March 28, 2002) AIDS vaccine models: Challenging challenge viruses Nature Medicine. (Posted: March 24, 2002) Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys Journal of Immunology. (Posted: March 4, 2002) The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: A dynamic model Journal of Acquired Immune Deficiency Syndromes. (Posted: March 4, 2002) The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND) Vaccine. (Posted: March 4, 2002) Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein Vaccine. (Posted: March 4, 2002) Vaccine development against HIV-1 - Current perspectives and future directions Immunologic Research. (Posted: March 4, 2002) Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy Journal of Virology. (Posted: March 4, 2002) Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure The Journal of Infectious Diseases. (Posted: February 19, 2002) Some recent results on HIV pathogenesis with implications for therapy and vaccines Cellular and Molecular Biology. (Posted: February 19, 2002) Safety and efficacy of an oral HIV vaccine (V-1 Immunitor) in AIDS patients at various stages of the disease HIV Clinical Trials. (Posted: February 12, 2002) The search for an HIV vaccine British Medical Journal. (Posted: February 5, 2002) First trial of the HIV-1 vaccine in Africa: Ugandan experience British Medical Journal. (Posted: February 5, 2002) Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells Virology. (Posted: February 4, 2002) Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine Clinical Immunology. (Posted: February 4, 2002) A retroviral DNA vaccine vector Viral Immunology. (Posted: January 28, 2002) A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques Journal of General Virology. (Posted: January 28, 2002) HIV-vaccine research takes one steps forward ... and one step back Lancet. (Posted: January 28, 2002) An HIV vaccine: how and when? Bulletin of the World Health Organization. (Posted: January 28, 2002) Potent CD4(+) T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF Journal of Immunology. (Posted: January 28, 2002) The past, present and future of HIV-vaccine development: a critical view Drug Discovery Today. (Posted: January 28, 2002) Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature. (Posted: January 28, 2002) Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes Nature. (Posted: January 28, 2002) Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1 Immunopharmacology and Immunotoxicology. (Posted: January 28, 2002) Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects Eur. J. Clin. Microbiol. Infect. Dis. (Posted: January 28, 2002) The basis for HIV immunotherapeutic vaccines Vaccine. (Posted: January 15, 2002) Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules Vaccine. (Posted: January 15, 2002) Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model Vaccine. (Posted: January 15, 2002) Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation Immunobiology. (Posted: January 15, 2002) Epidemiological considerations in planning HIV preventive vaccine trials AIDS. (Posted: January 15, 2002) Vaccines and immunology - Recent advances in HIV/AIDS vaccine development AIDS. (Posted: January 15, 2002) New insights into protective humoral responses and HIV vaccines AIDS. (Posted: January 15, 2002) Novel vaccine delivery systems: solutions to HIV vaccine dilemmas? AIDS. (Posted: January 15, 2002) The HIV vaccine pipeline, from preclinical to phase III AIDS. (Posted: January 15, 2002) Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine Vaccine. (Posted: January 15, 2002) Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization Journal of Virology. (Posted: January 14, 2002) Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development Immunological Reviews. (Posted: January 14, 2002) Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys Journal of Immunology. (Posted: January 14, 2002) Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine Journal of Immunology. (Posted: January 14, 2002) Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques Nature Medicine. (Posted: January 1, 2002) Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice Journal of Virology. (Posted: January 1, 2002) Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene Journal of Virology. (Posted: January 1, 2002) Imperfect vaccines and the evolution of pathogen virulence Nature. (Posted: December 16, 2001) Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies Journal of Virology. (Posted: December 7, 2001) Vaccine-elicited immune responses prevent clinical AIDS in SHIV89.6P-infected rhesus monkeys Immunol. Lett.. (Posted: November 29, 2001) Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? Immunol. Lett.. (Posted: November 29, 2001) Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector Vaccine. (Posted: November 28, 2001) Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes Nature Medicine. (Posted: November 28, 2001) HIV mucosal vaccine: Nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1-and Th2-deficient conditions J. Immunol.. (Posted: November 28, 2001) Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan Vaccine. (Posted: November 28, 2001) Rational development of prophylactic HIV vaccines based on structural and regulatory proteins Vaccine. (Posted: November 28, 2001) Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes Nature Medicine. (Posted: November 8, 2001) Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion Journal of Virology. (Posted: November 1, 2001) Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus Journal of Virology. (Posted: November 1, 2001) Recent developments in adjuvants for vaccines against infectious diseases Biomolecular Engineering. (Posted: November 1, 2001) HIV vaccine efforts inch forward Journal of the American Medical Association. (Posted: October 22, 2001) Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE Am J Public Health. (Posted: September 18, 2001) Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people American Journal of Preventive Medicine. (Posted: August 30, 2001) Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors Journal of Virology. (Posted: August 10, 2001) Immunomodulators and delivery systems for vaccination by mucosal routes Trends in Biotechnology. (Posted: August 10, 2001) Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites J. Immunol.. (Posted: August 1, 2001) Evolution and transmission of stable CTL escape mutations in HIV infection Nature. (Posted: July 27, 2001) Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis MMWR. (Posted: July 16, 2001) A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus HUMAN GENE THERAPY. (Posted: July 3, 2001) Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine? The HIVNET Vaccine Preparedness Study American Journal of Epidemiology. (Posted: April 2, 2001) AIDS vaccines show promise after years of frustration Science. (Posted: March 19, 2001) Microbicides in HIV Prevention British Medical Journal Online. (Posted: March 5, 2001) Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. Communities Journal of Acquired Immune Deficiency Syndromes. (Posted: February 5, 2001) Willingness to Participate in HIV Vaccine Trials Among Men Who Have Sex with Men in Rio de Janeiro, Brazil J. AIDS. (Posted: January 10, 2001)       Privacy Policy     Site Map       Published by the American Association for the Advancement of Science.     Copyright © 2003 by the American Association for the Advancement of Science.